BOSTON, June 22, 2023 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for…